Clinical trial
A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care
NCT02807857 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care
- Lead sponsor
- Novartis Pharmaceuticals
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 7, 2016
- Completion date
- March 23, 2018
- Enrollment
- 1,415 (actual)
- Sites
- 191
Conditions
As the registry lists them; a condition with its own page is linked.
chronic heart failure (chf)